Premier Biomedical (BIEI) Financial Statements
Premier Biomedical Financial Overview
Premier Biomedical's market cap is currently $1.27M. The company's EPS TTM is $0.00; its P/E ratio is -25.15; Premier Biomedical has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 1.02K | $ 14.28K |
| Gross Profit | $ 0.00 | $ -1.47K | $ -1.47K | $ -1.26K | $ 1.42K |
| Operating Income | $ -171.00K | $ -18.26K | $ -6.47K | $ -100.83K | $ -327.00K |
| EBITDA | $ -3.10K | $ -16.79K | $ -5.00K | $ -98.86K | $ 20.91K |
| Net Income | $ -202.00K | $ -49.26K | $ -38.77K | $ -403.17K | $ -374.00K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 4.21K | $ 0.00 | $ 0.00 | $ 0.00 | $ 71.20K |
| Total Assets | $ 7.35K | $ 3.13K | $ 3.13K | $ 4.60K | $ 100.94K |
| Total Debt | $ 568.34K | $ 437.39K | $ 435.99K | $ 418.19K | $ 160.75K |
| Net Debt | $ 564.13K | $ 437.39K | $ 435.99K | $ 418.19K | $ 89.55K |
| Total Liabilities | $ 2.49M | $ 2.28M | $ 2.25M | $ 2.22M | $ 1.93M |
| Stockholders' Equity | $ -2.48M | $ -2.28M | $ -2.25M | $ -2.22M | $ -1.83M |
| Cash Flow | |||||
| Free Cash Flow | $ -170.99K | $ 2.93K | $ -5.00K | $ -71.20K | $ -349.03K |
| Operating Cash Flow | $ -170.99K | $ 2.93K | $ -5.00K | $ -71.20K | $ -344.18K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -4.85K |
| Financing Cash Flow | $ 175.21K | $ 0.00 | $ 5.00K | $ 0.00 | $ 333.40K |
Currency in USD